Objective: This study aimed to investigate epidemiological characteristics of infections and risk factors for mortality in intensive care unit (ICU) patients.
INTRODUCTION
Nosocomial infection (NI) is one of the most important complications associated with hospitalization and causes an increase in mortality, morbidity, and treatment costs [1] . In particular, patients admitted to the ICU have an increased risk of developing hospital infections because of reduced host defenses, frequent use of invasive devices, and administration of drugs that predispose for infections [2] [3] [4] [5] . Moreover, the pathogens isolated in ICU infections have higher resistance rates to commonly used antimicrobial agents compared to those in community and hospital ward infections [3] .
Numerous risk factors affect mortality in the ICU. In previous studies, advanced age, diagnosis at admission, invasive procedures, and length of stay in the ICU were reported risk factors for mortality [6] [7] [8] . The association between infections and mortality was emphasized in many large series studies [1, 9] .
The first aim of this study was to determine the incidence of NIs and the etiological agents isolated in these infections. The second aim was to investigate risk factors for mortality.
METHODS
This study was carried out at a tertiary care hospital, Ankara Numune Education and Research Hospital, between April and December 2013. Both surgical and medical cases hospitalized in a 30-bed ICU over 48 hours were included in the study. The patients who were pregnant, younger than 18 years old, transferred from another ICU, or staying less than 48 hours in the ICU were excluded.
The patients were followed prospectively until they died or were discharged from the ICU. In addition to demographic characteristics of the patients, the standardized patient forms included the following information: dates of admission to the ICU and discharge from the ICU; primary reason for ICU admission; underlying diseases; history of surgical operation; usage of invasive devices and their duration for endotracheal intubation; urinary catheterization; nasogastric tube and central venous catheterization; NI at admission or acquired in ICU; culture results; antimicrobial treatment; and outcomes of cases. The APACHE II scores on the first day in the ICU were used to assess the severity of illness. Hematological and biochemical tests were performed every day. Deep tracheal aspirate and urine samples were cultured on admission and weekly afterward for surveillance. Chest plain radiography was performed weekly or in suspicion of pneumonia. Computed tomography was taken when chest radiography was inadequate for the diagnosis. Blood cultures and/ or intravascular catheter tips cultures were taken in suspicion of blood stream infection. In clinical suspicion of infection, deep tracheal aspirate, urine, or samples from other infection sites (wound, decubitus ulcers, or cerebrospinal fluid) were taken for culture. The infectious disease specialist visited the patients daily and collected data about clinical findings and development of infections, and if necessary ordered antimicrobial treatment. NIs were diagnosed according to the criteria of the Centers for Disease Control and Prevention, which are based on clinical and laboratory findings [10] . Infection at the time of admission was only accepted as a nosocomial infection when a new infection developed with a different microorganism or in another anatomical site during the ICU stay. Isolated bacteria were identified by conventional methods and tested for antibiotic susceptibility by the Kirby-Bauer disc diffusion technique according to Clinical and Laboratory Standards Institute (CLSI) specifications [11] . The BacT/ALERT® 3D Microbial Detection System (bioMerieux/France) was used for blood culture.
Patients were grouped as "died" and "survived" cases, and the groups were compared according to the following factors: age; gender; primary diagnosis at admission to the ICU; underlying diseases; length of ICU stay; development of the infections; 
Statistical Analysis
Statistical analyses were performed with Statistical Package for Social Sciences (SPSS) software, version 16.0. Chi-square, Mann-Whitney U, and logistic regression analysis tests were used. All p values <0.05 were considered significant.
RESULTS
A total of 164 patients were included in the study during a period of nine months, and 83 (50.4%) were male. The mean age was 66.6 ± 17.4 years, and 96.3% had at least one underlying disease, with neurological disorders (51.8%) being the most frequent. Of the patients, 15.2% had an operation one week before admission to the ICU, 13.4% had trauma history, and 29.9% had an infection at the time of admission to the ICU. The other demographic and clinical data of the patients is shown in Table  1 . Trauma, n (%) 22 (13.4) Infection at the admission to ICU 49 (29.9) During follow-up, 105 infection episodes occurred in 65 patients (39%). The incidence rate of NI was 64 infections per 100 patient admissions and 34.3 infections per 1000 patient days. Pneumonia (41%) was the most frequent infection, followed by urinary tract infection (26%) and catheter-related bacteremia (19%). The causative agents were detected in 46.0 % of the infections. A. baumannii was the most frequently isolated pathogen ( Table  2) . The most active antimicrobials against A. baumannii were colistin (97.3%) and tigecycline (83%). Carbapenem and piperacillin-tazobactam resistance rates among A. baumannii were 100%, while cefoperazone-sulbactam resistance rate was 80%. The crude mortality rate was 30.5% (50 patients). In a comparison of "died" and "survived" patients, there were no significant differences in terms of age, sex, and length of ICU stay. Underlying neurological diseases, infections acquired during ICU stay (especially surgical site infection and pneumonia), invasive device usage, isolation of A. baumannii from the patient samples, and APACHE II score ≥15 at admission were found as statistically significant risk factors for mortality in univariate analysis (P<0.005 for each) ( Table 3) . Multivariate logistic regression analysis showed that APACHE II score ≥15 at admission, surgical site infection acquired in the ICU, and isolation of A. baumannii were independent risk factors for mortality (P = 0.039, 0.040 and 0.025, respectively) ( 
DISCUSSION
Infections acquired during a stay in the ICU constitute a major part of NIs [3, 4, 12 infections [3, 9] . The incidence of infection is two to five times higher in ICUs than in the general inpatient population [5] . The NI rates in the ICU were reported in a wide range of 9.6 and 48.7% in the previous studies [6, 5, [13] [14] [15] , which includes the infection rate of 39.0% in the current study. In the Extended Prevalence of Infection in Intensive Care (EPIC) II study, conducted as a one-day point-prevalence study across Europe in 2007, infection rate was found to be 51%, higher than the previous rate of 20.6% reported in the 1992 EPIC study [9, 16] . The ICU infection rates may vary between centers, depending on the characteristics of patients and ICUs [15, 17] . Furthermore, there are some personal practical differences in implementation of surveillance methods and diagnostic criteria. For this reason, comparison of NI rates from different ICUs is difficult.
Pneumonia is reported to be the most frequent infection in the ICU, followed by urinary tract infection [4, 12] . Similarly, pneumonia was found to be the most frequent infection in the present study. This was similar to the results of the EPIC study, the EPIC II study, and the other studies [9, 13, 14, 16] . Pneumonia rates may vary based on ICU level and the rates of connecting to mechanical ventilation.
NIs in the present study were most frequently caused by A. baumannii, similar to the majority of studies in which gram-negative organisms were the predominant agent [13, 15, 16, 18] . Acinetobacter isolates were resistant to many antibiotics, including carbapenems. Due to the appearance of multidrug resistant pathogens, ICU infections have been considered a major threat for public health in recent years. Infection with multidrug resistant pathogens causes an increase in morbidity, mortality, and economic burden [3, 13, 16] . Frequent use of broad spectrum antibiotics causes ICU patients to become vulnerable to infections from multidrugresistant microorganisms [13] .
The mortality rates in the ICU were reported in the range of 19.6%-60% [2, 5, 6, 13, 15, [19] [20] [21] [22] , and several risk factors were described in the previous reports [6, 7, 13, 16, 17, 19] . Underlying disease was found associated with mortality in many studies [2, 7, 19, 22] . However, in the present study, underlying disease was not a significant risk factor for mortality. Older age was reported to be a risk factor for mortality in the majority of the studies [2, 5, 6, 16) . However, in the present study, older age was not found to be a risk factor for mortality, which was compatible with the study reported by Cevik et al. [6] .
Invasive procedures, especially mechanical ventilation, have been reported as risk factors for mortality in many studies [5] [6] [7] 9, 16, 19, 22, 23] . In the current study, mechanical ventilation, central venous catheter, and nasogastric catheter were associated with mortality by univariate analysis (P=0.001 for each), but there was no association between mortality and invasive procedures in multivariate analysis.
The association between mortality and disease severity scores has been investigated in many studies [5] [6] [7] 16, 22, [24] [25] [26] . A high APACHE II score was reported as an independent risk factor for mortality in the majority of previous studies [5, 7, 22, 25] , while some studies did not find an association between APACHE II score and mortality [2, 24] . In the current study, a high APACHE II score (≥15) at the time of admission was found to be significantly associated with mortality, which was consistent with the study of Meric et al. [5] .
Severe NIs and multidrug resistance (MDR) are associated with a poor prognosis for patients in intensive care units [1, 25] . In the majority of studies, infections acquired in the ICU were found to be independently associated with an increased risk for mortality [9, 16, 19, 27, 28] , while other studies did not find any association between infections and mortality [2, 13, 23] . The EPIC study showed an association between mortality and ICU-acquired pneumonia, clinical sepsis, and bloodstream infections [9] . Similarly, in the study of Cevik et al., pneumonia acquired in the ICU was associated with increased mortality [6] . In the present study, infections occurred significantly more frequently in patients in the "died" group than in the "survived" group in univariate analysis (p=0.013). However, multivariate analysis results indicated an association only between surgical site infections and mortality (p=0.040).
The impact of increased length of ICU stay on nosocomial infections and mortality has been investigated in many studies [5, 6, 8, 9, 15, 16, 20, 23, 29] . In the majority of the studies, increased length of stay was found to be an independent risk factor for ICU-acquired infection [5, 15, 16, 20, 23] . Some studies showed that the length of stay was longer in infected patients than in uninfected cases [13) . In this study, infection with A. baumannii caused an increase in the length of ICU stay, similar to the other studies [29, 30] . Hospitalization in the ICU for longer than 21 days was found to be an independent factor associated with mortality in the EPIC study [9] . The other studies also showed an increase in mortality rate in cases of prolonged hospitalization [8, 20] . In the present study, the length of ICU stay was not statistically different between patients in the "died" and "survived" groups, which was consistent with the study of Cevik et al. [6] .
Due to its high level of resistance to many antibiotics, A. baumannii has become a pathogen that is difficult to treat [16] . The majority of studies showed that A. baumannii infection was an independent risk factor for mortality [3, 8] , while a few studies investigating outcomes of infection in the ICU showed that A. baumannii infection was not associated with mortality [24, 29] . In the present study, A. baumannii infection was found to be an independent risk factor for mortality (p=0.025). A. baumannii has recently emerged as an important nosocomial pathogen and mainly affects patients with impaired host defenses in the ICU. Resistance to commonly used antibiotics, including cephalosporins, aminoglycosides, quinolones, and carbapenems is another concern relating to A. baumannii infection [3] .
In conclusion, a high APACHE II score at admission, surgical site infection, and infections caused by A. baumannii increase the mortality rates in the ICU. In addition, infection caused by A. baumannii is associated with increased duration of ICU stay. The treatment of A. baumannii infections is difficult due to a higher resistance rate to commonly used antibiotics. In order to decrease the mortality rates, empirical treatment should cover A. baumannii isolates in endemic ICUs.
